Cases
LifePoint Health, Inc. (LPNT)
Merger
Overview
Overview
- Date:
- 7/23/2018
- Company Name:
- LifePoint Health, Inc.
- Stock Symbol:
- LPNT
- Company Name - Buyer:
- Apollo Global Management, L.L.C.
- Status:
- Closed/Complete
- Merger Announcement Date:
- 7/23/2018
NEW YORK, July 23, 2018 – Bragar Eagel & Squire, P.C. is investigating potential claims against LifePoint Health, Inc. (NYSE: LPNT) on behalf of stockholders concerning the proposed transaction with Apollo Global Management, LLC.
Pursuant to the proposed transaction, announced on July 23, 2018 and valued at approximately $5.6 billion, LifePoint stockholders will receive $65.00 in cash for their LifePoint common stock. Our investigation concerns whether LifePoint’s board of directors failed to adequately shop the company and obtain the best possible price for its stockholders before entering into a definitive agreement with Apollo Global Management.
If you own LifePoint shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa Fortunato by email at investigations@bespc.com, or telephone at (212) 308-1869, or by filling out the contact form below. There is no cost or obligation to you.
Pursuant to the proposed transaction, announced on July 23, 2018 and valued at approximately $5.6 billion, LifePoint stockholders will receive $65.00 in cash for their LifePoint common stock. Our investigation concerns whether LifePoint’s board of directors failed to adequately shop the company and obtain the best possible price for its stockholders before entering into a definitive agreement with Apollo Global Management.
If you own LifePoint shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa Fortunato by email at investigations@bespc.com, or telephone at (212) 308-1869, or by filling out the contact form below. There is no cost or obligation to you.